Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Biliary Tract Diseases

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    January 2024
  1. SEXTON F, Shanahan W, Ryan JD
    Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102255.
    PubMed    


  2. NAYAGAM JS, Ahmed W, Farrant M, Jefferies J, et al
    Clinical factors associated with illness perception, worry and mental health in sclerosing cholangitis: A single centre prospective study.
    Clin Res Hepatol Gastroenterol. 2024;48:102251.
    PubMed     Abstract available


    December 2023
  3. ZHENG L, Zhou N, Yang X, Wei Y, et al
    Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
    Clin Res Hepatol Gastroenterol. 2023;47:102244.
    PubMed     Abstract available


  4. JANG H, Han N, Staatz CE, Kwak JH, et al
    Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023;47:102227.
    PubMed     Abstract available


    November 2023
  5. PASCALE A, Rosmorduc O, Duclos-Vallee JC
    New epidemiologic trends in cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2023;47:102223.
    PubMed     Abstract available


  6. MUTANEN A, Pakarinen MP
    Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102220.
    PubMed     Abstract available


    October 2023
  7. FILANOVSKY K, Temper N, Stanevsky A, Shvidel L, et al
    Vanishing bile duct syndrome in a patient with multiple myeloma treated with bortizomib, lenalidomide and dexamethasone.
    Clin Res Hepatol Gastroenterol. 2023;47:102198.
    PubMed    


  8. DI GIORGIO A, Sciveres M, Fuoti M, Sonzogni A, et al
    Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency.
    Clin Res Hepatol Gastroenterol. 2023;47:102185.
    PubMed     Abstract available


  9. BOILLOT O, Guillaud O, Wischlen E, Ruiz M, et al
    Determinants of early surgical complications after pediatric liver transplantation: A single center/single surgeon experience over 20 years.
    Clin Res Hepatol Gastroenterol. 2023;47:102222.
    PubMed     Abstract available


    August 2023
  10. VO QUANG E, Ithier G, Jager M, Plessier A, et al
    Cholangiopathy in sickle cell disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102166.
    PubMed    


    May 2023
  11. WISCHLEN E, Laverdure N, Erard D, Rohmer B, et al
    Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
    Clin Res Hepatol Gastroenterol. 2023;47:102139.
    PubMed     Abstract available


  12. MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al
    Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102114.
    PubMed     Abstract available


  13. YU AT, Khajoueinejad N, Gross A, Golas BJ, et al
    A possible role for ketorolac in the management of increased biliary drain output.
    Clin Res Hepatol Gastroenterol. 2023;47:102128.
    PubMed     Abstract available


    April 2023
  14. SHIAU H, Schraw JM, Mysore K, Cavallo L, et al
    Characteristics of infections and their risk factors in children with biliary atresia.
    Clin Res Hepatol Gastroenterol. 2023;47:102109.
    PubMed     Abstract available


  15. SASAKI M, Sato Y, Nakanuma Y
    An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2023;47:102106.
    PubMed     Abstract available


    December 2022
  16. FERREIRA FB, Mourato M, Braganca S, Paulo JB, et al
    COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients.
    Clin Res Hepatol Gastroenterol. 2022;46:102048.
    PubMed     Abstract available


  17. NEUZILLET C, Malka D, Lievre A, Khurana IS, et al
    Correlation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: Analysis of aggregated data from a systematic literature review.
    Clin Res Hepatol Gastroenterol. 2022;46:102010.
    PubMed     Abstract available


    November 2022
  18. WASUWANICH P, Choudry H, So JM, Lowry S, et al
    Vanishing bile duct syndrome after drug-induced liver injury.
    Clin Res Hepatol Gastroenterol. 2022;46:102015.
    PubMed     Abstract available


  19. WU L, Yang J, Ke RS, Liu Y, et al
    Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101999.
    PubMed     Abstract available


    October 2022
  20. WANG J, Lun W, Shi W
    Effects of elevated bile acid levels on fetal myocardium in intrahepatic cholestasis of pregnancy, a retrospective study from a neonatal perspective.
    Clin Res Hepatol Gastroenterol. 2022;46:102013.
    PubMed     Abstract available


  21. BRAN DM, Fuks D, Lansier A, Gallois C, et al
    Pathological complete response of liver metastases of cholangiocarcinoma using hepatic intra-arterial gemcitabine-oxaliplatin.
    Clin Res Hepatol Gastroenterol. 2022;46:101920.
    PubMed    


    September 2022
  22. COILLY A, Sebagh M, Fougerou-Leurent C, Pageaux GP, et al
    HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2022 Sep 16:102024.
    PubMed     Abstract available


    August 2022
  23. YANG SH, Hu S, Kang Q, Liu LX, et al
    EIF5A2 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells.
    Clin Res Hepatol Gastroenterol. 2022;46:101991.
    PubMed     Abstract available


  24. JIANG H, Li W, Xue Z, Chen W, et al
    lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
    Clin Res Hepatol Gastroenterol. 2022;46:101915.
    PubMed     Abstract available


    June 2022
  25. NAYAGAM JS, Mandour MO, Taylor A, Heneghan MA, et al
    Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022 Jun 18:101980.
    PubMed     Abstract available


    April 2022
  26. JAIN A, Kirkpatrick RB, Sobotka LA
    Severe pruritis during pregnancy: More than just intrahepatic cholestasis of pregnancy?
    Clin Res Hepatol Gastroenterol. 2022;46:101875.
    PubMed    


    March 2022
  27. CAMPOS-PEREZ W, Perez-Robles M, Rodriguez-Echevarria R, Rivera-Valdes JJ, et al
    High dietary omega-6:omega-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2022;46:101802.
    PubMed     Abstract available


  28. ADAMS T, Liebe R, Lehmann J, Krawczyk M, et al
    Acute cholestatic liver injury following carbimazole treatment in a patient with VPS33B haploinsufficiency.
    Clin Res Hepatol Gastroenterol. 2022;46:101803.
    PubMed    


  29. BATOOL SS, Dauer M, Weber SN, Liebe R, et al
    Intrahepatic cholestasis of pregnancy in conjunction with a frameshift deletion in FGFR4.
    Clin Res Hepatol Gastroenterol. 2022;46:101800.
    PubMed     Abstract available


    February 2022
  30. JULIA S, Peter S, Karl-Heinz W, Daniel Nils G, et al
    Possible role of the HMGB1 and RAGE inflammatory pathway in primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101791.
    PubMed     Abstract available


  31. SONG S, Yang W, Tian H, Gong S, et al
    The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101788.
    PubMed     Abstract available


    January 2022
  32. NAULT JC, Blanc JF, Moga L, Calderaro J, et al
    Non-invasive diagnosis and follow-up of benign liver tumours.
    Clin Res Hepatol Gastroenterol. 2022;46:101765.
    PubMed     Abstract available


  33. CHAZOUILLERES O, Potier P, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101775.
    PubMed     Abstract available


  34. CORPECHOT C, Heurgue A, Tanne F, Potier P, et al
    Non-invasive diagnosis and follow-up of primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101770.
    PubMed     Abstract available


  35. LEMOINNE S, Heurgue A, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of autoimmune hepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101772.
    PubMed     Abstract available


    November 2021
  36. BOURDELEAU P, Larrey E, Allaire M, Charlotte F, et al
    "De novo" Cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!
    Clin Res Hepatol Gastroenterol. 2021 Nov 2:101827.
    PubMed     Abstract available


  37. XU ZL, Ou YJ, Dai HS, Wan K, et al
    Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
    Clin Res Hepatol Gastroenterol. 2021;45:101695.
    PubMed     Abstract available


  38. REN T, Pang L, Dai W, Wu S, et al
    Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases.
    Clin Res Hepatol Gastroenterol. 2021;45:101641.
    PubMed     Abstract available


  39. ORLOWSKA E, Czubkowski P, Wolochowska K, Jarzebicka D, et al
    Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial.
    Clin Res Hepatol Gastroenterol. 2021;45:101753.
    PubMed     Abstract available


  40. LOPEZ DE FRUTOS L, Cebolla JJ, de Castro-Oros I, Irun P, et al
    Neonatal cholestasis and Niemann-pick type C disease: A literature review.
    Clin Res Hepatol Gastroenterol. 2021;45:101757.
    PubMed     Abstract available


    September 2021
  41. NAKAMURA H, Ara M, Koga H, Miyano G, et al
    Duration from the first pale stool to portoenterostomy is prognostic in biliary atresia. Comparison with age at portoenterostomy.
    Clin Res Hepatol Gastroenterol. 2021;45:101584.
    PubMed     Abstract available


  42. ZIMMER V
    Intraductal vacuum suction for high biliary stone retrieval during direct cholangioscopy.
    Clin Res Hepatol Gastroenterol. 2021;45:101600.
    PubMed    


  43. BAUMANN U, Sturm E, Lacaille F, Gonzales E, et al
    Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Clin Res Hepatol Gastroenterol. 2021;45:101751.
    PubMed     Abstract available


    July 2021
  44. PERRAULT F, Echelard P, Viens D, Borduas M, et al
    Contraceptive vaginal ring-induced cholestasis in a patient with a history of intrahepatic cholestasis of pregnancy.
    Clin Res Hepatol Gastroenterol. 2021;45:101475.
    PubMed     Abstract available


    May 2021
  45. ZIMMER V, Reichert MC, Lammert F
    Cholesterol crystals in biliary cast syndrome related to sclerosing cholangitis in critically ill patients.
    Clin Res Hepatol Gastroenterol. 2021;45:101485.
    PubMed    


  46. LYKAVIERIS P, Bernard O, Jacquemin E
    Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.
    Clin Res Hepatol Gastroenterol. 2021;45:101472.
    PubMed    


  47. KULKARNI AV, Tevethia HV, Arab JP, Candia R, et al
    Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021;45:101675.
    PubMed     Abstract available


    March 2021
  48. CORPECHOT C
    The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to "UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis" by Pedersen et al., Liver Transplant, Nove
    Clin Res Hepatol Gastroenterol. 2021 Mar 13:101679.
    PubMed    


  49. FAMULARO G, Spada PL
    COVID-19-related cholecystitis.
    Clin Res Hepatol Gastroenterol. 2021;45:101635.
    PubMed    


  50. DI GIORGIO A, Nicastro E, Arnaboldi S, Montini O, et al
    "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study".
    Clin Res Hepatol Gastroenterol. 2021;45:101610.
    PubMed    


  51. WANG P, Tao H, Liu C, Zhou X, et al
    One-step percutaneous transhepatic cholangioscopic lithotripsy in patients with choledocholithiasis.
    Clin Res Hepatol Gastroenterol. 2021;45:101477.
    PubMed     Abstract available


  52. YILDIRIM M, Artas H, Artas G
    False-positive PET/CT finding of hepatic inflammatory pseudotumor in IgG4-related sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2021;45:101645.
    PubMed    


  53. SHEN X, Huang Y, Guo H, Peng H, et al
    Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus.
    Clin Res Hepatol Gastroenterol. 2021;45:101495.
    PubMed     Abstract available


    January 2021
  54. LI Y, Hu M, Li L, Liu S, et al
    Successful response to monotherapy of immune checkpoint inhibitor in intrahepatic cholangiocarcinoma with high tumor mutational burden and PD-L1 expression.
    Clin Res Hepatol Gastroenterol. 2021;45:101525.
    PubMed    


  55. KANG Y, Park S, Kim S, Han SJ, et al
    Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix.
    Clin Res Hepatol Gastroenterol. 2021;45:101437.
    PubMed     Abstract available


    November 2020
  56. ZHAI LL, Xiang F, Wang W, Wu L, et al
    Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis.
    Clin Res Hepatol Gastroenterol. 2020;44:e135-e140.
    PubMed     Abstract available


    October 2020
  57. COUCHONNAL E, Jacquemin E, Lachaux A, Ackermann O, et al
    Long-term results of pediatric liver transplantation for autoimmune liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Oct 16. pii: S2210-7401(20)30275.
    PubMed     Abstract available


  58. RAHAL HK, Tabibian JH
    The MBOAT7 rs641738 variant in primary sclerosing cholangitis: A novel biomarker for prognostication.
    Clin Res Hepatol Gastroenterol. 2020;44:619-621.
    PubMed    


    June 2019
  59. RAUBER C, Awad M, Koschny R, Sauer P, et al
    Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study.
    Clin Res Hepatol Gastroenterol. 2019 Jun 11. pii: S2210-7401(19)30102.
    PubMed     Abstract available


  60. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.